Categories AlphaGraphs, Earnings, Retail

Macy’s first quarter results beat expectations; lifts outlook

Shares of Macy’s Inc. (M) were up 9% during the pre-market trading after it reported upbeat results for the first quarter and raised the outlook for the year. Macy’s stock, which jumped about 27% so far this year, spiked 7% when the market opened today. Net sales increased 3.6% to $5.54 billion compared to last year. Comparable sales on an owned basis were up 3.9% while comp sales on an owned plus licensed basis were up 4.2%.

Net income attributable to shareholders was $139 million or $0.45 per share compared to $78 million or $0.26 per share in the prior-year period. Adjusted diluted EPS was $0.48.

Macy's first quarter 2018 earnings

Macy’s Q1 2018 Earnings Infographics

The Cincinnati-based retailer said the results exceeded its expectations and performance was strong across all brands and geographical regions. Inventory is in a stable position while physical stores along with the ecommerce and digital channels continue to perform well. Macy’s digital business grew in the double-digits during the quarter.

Macy’s decided to end its JV with Fung Retailing Limited in China but will continue to operate on TMall and other social media platforms.

The company, which battles with retail giants like Amazon (AMZN) and Walmart (WMT), lifted its guidance for the fiscal year 2018. Currently, adjusted EPS is targeted to be $3.75 to $3.95 compared with the previous guided range of $3.55 to $3.75. Total sales are expected to range from a 1% decline to a 0.5% increase in 2018. Comparable sales on an owned plus licensed basis are expected to increase 1-2%.

Despite the solid results, Macy’s is not safe from the Amazon effect, and neither are its peers. Macy’s is undertaking several initiatives to tackle this competition including focusing on Macy’s Backstage. The company’s acquisition of concept store Story is part of these efforts.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top